In focus
Latest feed
Johnson & Johnson's Bold Bet: Steering Clear of GLP-1 Hype to Double Down on Oncology
The Unveiling: Trump's Most Favored Nation Drug Pricing Secrets Are About To Surface
The Unseen Hand: How Pharma Giants Shape Policy Through Academic Influence
Unpacking Pharma's Future: Costs, Generics, and the Tug-of-War for Access